Clinical Trials Browser

Phase 2 × bafetinib × Other hematologic neoplasm × Clear all

NCT01144260 2013-05-15

Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell